Osaic Holdings’s Avidity Biosciences RNAM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | – | Sell |
-305
| Closed | -$22K | – | 8030 |
|
|
2025
Q4 | $22K | Sell |
305
-2,883
| -90% | -$186K | ﹤0.01% | 5822 |
|
|
2025
Q3 | $139K | Buy |
3,188
+1,552
| +95% | +$62.7K | ﹤0.01% | 4510 |
|
|
2025
Q2 | $47.7K | Buy |
1,636
+1,543
| +1,659% | +$46K | ﹤0.01% | 5088 |
|
|
2025
Q1 | $2.75K | Sell |
93
-319
| -77% | -$9.94K | ﹤0.01% | 6470 |
|
|
2024
Q4 | $12K | Sell |
412
-717
| -64% | -$30K | ﹤0.01% | 5669 |
|
|
2024
Q3 | $51.9K | Buy |
1,129
+528
| +88% | +$22.9K | ﹤0.01% | 4721 |
|
|
2024
Q2 | $24.6K | Buy |
601
+466
| +345% | +$13.4K | ﹤0.01% | 5197 |
|
|
2024
Q1 | $3.44K | Sell |
135
-400
| -75% | -$6.27K | ﹤0.01% | 6249 |
|
|
2023
Q4 | $4.84K | Sell |
535
-200
| -27% | -$1.34K | ﹤0.01% | 6189 |
|
|
2023
Q3 | $4.69K | Buy |
735
+398
| +118% | +$3.43K | ﹤0.01% | 6301 |
|
|
2023
Q2 | $3.73K | Sell |
337
-252
| -43% | -$3.16K | ﹤0.01% | 6438 |
|
|
2023
Q1 | $9.04K | Buy |
589
+246
| +72% | +$5.41K | ﹤0.01% | 6033 |
|
|
2022
Q4 | $7K | Buy |
343
+143
| +72% | +$2.13K | ﹤0.01% | 6142 |
|
|
2022
Q3 | $3K | Hold |
200
| – | – | ﹤0.01% | 6661 |
|
|
2022
Q2 | $3K | Hold |
200
| – | – | ﹤0.01% | 6753 |
|
|
2022
Q1 | $3K | Sell |
200
-11
| -5% | -$187 | ﹤0.01% | 6760 |
|
|
2021
Q4 | $4K | Buy |
211
+190
| +905% | +$4.54K | ﹤0.01% | 6774 |
|
|
2021
Q3 | $1K | Sell |
21
-279
| -93% | -$6.06K | ﹤0.01% | 7064 |
|
|
2021
Q2 | $7K | Sell |
300
-250
| -45% | -$5.82K | ﹤0.01% | 6257 |
|
|
2021
Q1 | $12K | Buy |
+550
| New | +$13.5K | ﹤0.01% | 5791 |
|
Other funds holding RNAM
Osaic Holdings's RNAM Position: Q1 2026 in Review
Osaic Holdings sold out of Avidity Biosciences (RNAM) in Q1 2026, closing a stake of 305 shares — an estimated $22K sold.
Osaic Holdings first reported a position in RNAM in Q1 2021 and held it in 20 quarters. The position peaked at $139K in Q3 2025. 1 fund tracked by Wall St. Rank holds RNAM as of Q1 2026.
- Osaic Holdings reported no remaining Avidity Biosciences position as of Q1 2026 after selling out during the quarter.
- Osaic Holdings sold 305 Avidity Biosciences shares in Q1 2026, an estimated $22K.
- Osaic Holdings first reported a position in Avidity Biosciences in Q1 2021 and held it in 20 quarters.
- Osaic Holdings's Avidity Biosciences position peaked at $139K in Q3 2025.
- 1 fund tracked by Wall St. Rank held Avidity Biosciences as of Q1 2026.
Based on Osaic Holdings's 13F filing for Q1 2026, filed 15 May 2026.